Chronic Limb-Threatening Ischemia and the Need for Revascularization
- PMID: 37048765
- PMCID: PMC10095037
- DOI: 10.3390/jcm12072682
Chronic Limb-Threatening Ischemia and the Need for Revascularization
Abstract
Background: Patients presenting with critical limb-threatening ischemia (CLTI) have been increasing in number over the years. They represent a high-risk population, especially in terms of major amputation and mortality. Despite multiple guidelines concerning their management, it continues to be challenging. Decision-making between surgical and endovascular procedures should be well established, but there is still a lack of consensus concerning the best treatment strategy. The aim of this manuscript is to offer an overview of the contemporary management of CLTI patients, with a focus on the concept that evidence-based revascularization (EBR) could help surgeons to provide more appropriate treatment, avoiding improper procedures, as well as too-high-risk ones.
Methods: We performed a search on MEDLINE, Embase, and Scopus from 1 January 1995 to 31 December 2022 and reviewed Global and ESVS Guidelines. A total of 150 articles were screened, but only those of high quality were considered and included in a narrative synthesis.
Results: Global Vascular Guidelines have improved and standardized the way to classify and manage CLTI patients with evidence-based revascularization (EBR). Nevertheless, considering that not all patients are suitable for revascularization, a key strategy could be to stratify unfit patients by considering both clinical and non-clinical risk factors, in accordance with the concept of individual residual risk for every patient. The recent BEST-CLI trial established the superiority of autologous vein bypass graft over endovascular therapy for the revascularization of CLTI patients. However, no-option CLTI patients still represent a critical issue.
Conclusions: The surgeon's experience and skillfulness are the cornerstones of treatment and of a multidisciplinary approach. The recent BEST-CLI trial established that open surgical peripheral vascular surgery could guarantee better outcomes than the less invasive endovascular approach.
Keywords: chronic limb-threatening ischemia; endovascular treatment; lower-limb revascularization; peripheral arterial disease; peripheral bypass.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244. J Vasc Surg. 2019. PMID: 30579443 Free PMC article.
-
Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.J Vasc Surg. 2020 Dec;72(6):1987-1995. doi: 10.1016/j.jvs.2020.03.029. Epub 2020 Apr 8. J Vasc Surg. 2020. PMID: 32276010
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S110-S119. doi: 10.1016/j.ejvs.2019.04.013. Epub 2019 Jun 17. Eur J Vasc Endovasc Surg. 2019. PMID: 31221539
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):126S-136S. doi: 10.1016/j.jvs.2018.01.071. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159976
-
Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.J Vasc Surg. 2023 Apr;77(4):1137-1146.e3. doi: 10.1016/j.jvs.2022.12.036. Epub 2022 Dec 27. J Vasc Surg. 2023. PMID: 36584906
Cited by
-
Fetal progenitor cells for treatment of chronic limb ischemia.Am J Stem Cells. 2024 Jun 15;13(3):169-190. doi: 10.62347/MZKI8393. eCollection 2024. Am J Stem Cells. 2024. PMID: 39021376 Free PMC article.
-
Peripheral Interventional Strategy Assessment (PISA) for Diabetic Foot Ulcer Revascularization: Preliminary Outcomes of a Multidisciplinary Pilot Study.Diagnostics (Basel). 2023 Sep 8;13(18):2879. doi: 10.3390/diagnostics13182879. Diagnostics (Basel). 2023. PMID: 37761246 Free PMC article.
-
Effectiveness of quality and quantity mononuclear cells for enhancing wound healing in diabetic ischemic limb animal model.Int Wound J. 2025 Apr;22(4):e70106. doi: 10.1111/iwj.70106. Int Wound J. 2025. PMID: 40192089 Free PMC article.
-
Safety and efficacy of chocolate balloon in the treatment of infrapopliteal artery disease.CVIR Endovasc. 2025 Jan 7;8(1):3. doi: 10.1186/s42155-024-00501-2. CVIR Endovasc. 2025. PMID: 39776384 Free PMC article.
-
Complex Peripheral Arterial Disease in a Case of Multilevel Lesions Treated With Sequential Angioplasty.Cureus. 2024 May 24;16(5):e60982. doi: 10.7759/cureus.60982. eCollection 2024 May. Cureus. 2024. PMID: 38915963 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous